載入...
18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
BACKGROUND: (18)F‐florbetapir uptake by brain tissue measured by positron emission tomography (PET) is accepted by regulatory agencies like the Food and Drug Administration (FDA) and the European Medicine Agencies (EMA) for assessing amyloid load in people with dementia. Its added value is mainly de...
Na minha lista:
| 發表在: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Ltd
2017
|
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486090/ https://ncbi.nlm.nih.gov/pubmed/29164603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012216.pub2 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|